Q3 2022 Vivoryon Therapeutics NV Earnings Call Transcript

Nov 22, 2022 / 02:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by. Welcome, and thank you for joining the Vivoryon Therapeutics Q3 Results 2022 Conference Call. (Operator Instructions) I would now like to turn the conference over to Manuela. Please go ahead.

Manuela Bader - Vivoryon Therapeutics N.V. - Director of IR & Communications

Thank you, Timo. Good afternoon, and thank you for joining us today for Vivoryon's conference call to discuss the company's third quarter 2022 results and operational progress to date. This morning, Vivoryon issued a press release reporting its third quarter 2022 results, which is posted on the company's website at www.vivoryon.com.

On the call with me today are Ulrich Dauer, Chief Executive Officer of Vivoryon; as well as Florian Schmid, our Chief Financial Officer; and Michael Schaeffer, our Chief Business Officer, who will be available for questions. We will begin today's call with opening remarks from Ulrich on Vivoryon's approach to overcoming the challenges of AD drug

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot